Safety, Activity, and Pharmacology of Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

Administered By

Awarded By

Contributors

Start/End

  • November 11, 2019 - August 20, 2020